Consider This Burnout Survey When Considering Your Specialty

Published Date: 20 May 2026

Burnout is a problem in every specialty, but there’s high variability.

Read Full News

Latest News

Social Media Sunscreen Recipes Raise Safety Concerns

Homemade sunscreen recipes are gaining attention, but laboratory studies suggest they may reduce ultraviolet damage unevenly and fail against key sunburn markers.

Cutaneous Lupus Flares Peak During Late Perimenopause

Cutaneous lupus flares increase during late perimenopause and remain elevated after menopause, study finds.

Somatic Cancer Symptoms May Be Overattributed to Depression

Experts offer advice for treating symptoms of ovarian, breast, and other cancers that are not driven by depression and explain why it’s essential to discern the difference.

UKHSA: New Pandemic More Than 25% Likely Within 5 Years

Influenza and novel coronavirus top a new UKHSA threat register covering 22 risks, from dengue to drug-resistant infections.

Most OTC Vaginal Moisturizers Contain Contact Allergens

Over-the-counter vaginal and vulvar moisturizers often contain allergens, with inaccurate marketing claims, a study shows.

Takeda's AI-crafted Psoriasis Pill Tops Bristol Myers' Sotyktu in Head-to-head Trial

Japan's Takeda Pharmaceutical said on Thursday its experimental once-daily psoriasis pill, developed with the help of AI, outperformed Bristol ⁠Myers Squibb's approved drug...

Todays Updates

Inside the Major Findings From the NHS-Galleri Trial

The largest randomized study of a multicancer blood test found no reduction in late-stage cancers, while raising new questions about stage shift, mortality benefit, and population screening.

Talquetamab Combos Show Survival Benefit in r/r Myeloma

Interim findings from the phase 3 MonumenTAL-3 trial highlight overall and progression-free survival as well as response rates compared with standard therapy.

Todays Updates

Inside the Major Findings From the NHS-Galleri Trial

The largest randomized study of a multicancer blood test found no reduction in late-stage cancers, while raising new questions about stage shift, mortality benefit, and population screening.

Talquetamab Combos Show Survival Benefit in r/r Myeloma

Interim findings from the phase 3 MonumenTAL-3 trial highlight overall and progression-free survival as well as response rates compared with standard therapy.

Latest News

Homemade sunscreen recipes are gaining attention, but laboratory studies suggest they may reduce ultraviolet damage unevenly and fail against key sunburn markers.

Cutaneous lupus flares increase during late perimenopause and remain elevated after menopause, study finds.

Experts offer advice for treating symptoms of ovarian, breast, and other cancers that are not driven by depression and explain why it’s essential to discern the difference.

Influenza and novel coronavirus top a new UKHSA threat register covering 22 risks, from dengue to drug-resistant infections.

Over-the-counter vaginal and vulvar moisturizers often contain allergens, with inaccurate marketing claims, a study shows.

Japan's Takeda Pharmaceutical said on Thursday its experimental once-daily psoriasis pill, developed with the help of AI, outperformed Bristol ⁠Myers Squibb's approved drug...

News All Time

Can Oral Icotrokinra Relieve High-Impact Site Psoriasis?

Icotrokinra yields high clearance and durable response rates at high-impact sites in patients with psoriasis, with no added adverse events compared with placebo, a 1-year assessment of a trial shows.

Pictogram Decision Aid Tool Improves HCQ Adherence in Lupus

A pictogram-based shared decision-making tool improves hydroxychloroquine adherence and reduces decisional conflicts in patients with SLE while requiring less time to deliver.

Durable Benefit Seen With Personalized Melanoma Vaccine

For patients with high-risk resected melanoma, adding the mRNA vaccine intismeran to pembrolizumab continued to stave off recurrence and distant metastases at 5 years.

Monthly Triple-Drug Combo Lowers Immune Reactions in Leprosy

Monthly rifampin-moxifloxacin-minocycline therapy lowers the risk for type 1 reactions in patients with Hansen disease, study shows.

Abivax's Inflammatory Bowel Drug Meets Main Goal Of Late Stage Trial

Abivax said on Monday its experimental drug for patients with ulcerative colitis, a type of chronic inflammatory disease, met ⁠the main goal of a closely watched late-stage...

US CDC Flags Health Risks Linked to Travel-related Cosmetic Procedures

The U.S. Centers for Disease Control and Prevention said on Tuesday that many Americans suffered serious complications — ⁠including bacterial infections and, in some cases,...

Sacroiliitis Worsening Commonly Found in Psoriatic Arthritis

A new study has uncovered factors associated with sacroiliitis progression in patients with psoriatic arthritis, as well as protective factors such as use of biologic and targeted DMARDs.

Birch Extract Boosts Wound Healing in EB: Long-Term Data

Oleogel-S10 accelerates wound healing and reduces wound burden in children with epidermolysis bullosa, a study finds.

Camp Victory: Support, Connections for Kids With Vitiligo

A unique camp brings together children and youth with vitiligo and their parents to talk about their challenges. They don’t want to leave.

Doctor Helps Woman Stop Blaming Herself and Accept Treatment

When an oncologist learns one patient’s story, everything shifts, including his approach to consultations.

IBS: New Dietetic Guidance Advises to ‘Think Beyond Diet’

Updated BDA guidance moves away from a diet-first approach to IBS, urging dietitians to consider lifestyle, mental health, and nondietary factors.

From K-pop to K-glow: Lasers, Face Firming Drive S Korea Tourism

Just over 2 million foreigners visited South Korea last year for medical treatment, nearly double the 2024 figure of ‌1.17 million.

Mohs for Rare Skin Cancer Linked to Lower Recurrence vs WLE

Mohs micrographic surgery reduces positive margins and 5-year recurrence in patients with dermatofibrosarcoma protuberans, compared with wide local excision, study finds.

The Potential for Remission, Cure in Psoriasis

'With the IL-23 blockers, for the first time ever, we've … seen a disconnect between drug levels in the blood and the ability to stay in remission,' says Andrew Blauvelt, MD.

FDA Approves OTC Switch for Topical Acne Treatment

The product combining adapalene 0.1% and benzoyl peroxide 2.5% was approved as a prescription acne treatment in December 2008 for patients aged 12 years and older.

Genital Lesions Most Common Sign of CCD

Most patients with cutaneous Crohn’s disease present with genital lesions and show good response with biologic therapy, according to a study shows.

Recommended News For You

Dendritic Cell Therapy Offers No Survival Advantage in Pleural Mesothelioma

Best foot forward—chemo care should include podiatry, say researchers

Avoiding Neuropathy From Chemo; Predictive Value of Screening EKGs

Omicron Infections Are Usually Cleared Up in Immunocompromised Patients.

'CDC Must Be Investigated'; David Lynch, Bob Uecker Die; Nasal Epinephrine Warning

June 20, 2023, Health Bulletin No. 12.

Study reveals link between new-onset type 2 diabetes and some obesity-related cancers

Recommended Articles For You

The Mysterious World of Petechiae: Exploring Causes and Treatments 

TAR-200 in Bladder Cancer: Precision Drug Delivery Driving Oncology Advances 

Beyond the Tumor: Emerging Frontiers in Cancer Systems Biology 

Unlocking the Potential of CPK Levels: How to Maximize Your Health Benefits 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Video: How to treat kidney disease?

2.

DNA origami offers more accurate imaging in the fight against pancreatic cancer

3.

After targeted agents, a novel bispecific in EGFR-mutant lung cancer improves PFS.

4.

How to keep your prostate healthy and lower your risk of developing serious problems

5.

Why alarm is easing over a rise in pancreatic cancer among the young

1.

Clinical Methods in Hematology and Quality Improvement

2.

Vaso Occlusive Crisis: Understanding the Painful Reality of Sickle Cell Disease

3.

Revolutionizing Cancer Treatment: How Adoptive Cell Therapy is Overcoming Tumor Immune Evasion

4.

Case Study: Diagnostic and Therapeutic Challenges in Aplastic Anemia Mimicking Hypoplastic Myelodysplastic Syndrome

5.

The Silent Danger of Hematoma: How to Identify and Treat This Potentially Serious Condition

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC

2.

A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC

3.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II

4.

Efficient Management of First line ALK-rearranged NSCLC - Part VII

5.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Further Discussion on A New Perspective

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot